

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.69109840 |
| 2 | muscle filament sliding (GO:0030049) | 8.49035684 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.49035684 |
| 4 | cardiac myofibril assembly (GO:0055003) | 7.94469887 |
| 5 | myofibril assembly (GO:0030239) | 7.91829094 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 7.72965986 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.51661080 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 7.18902986 |
| 9 | actin-mediated cell contraction (GO:0070252) | 7.09119384 |
| 10 | regulation of relaxation of muscle (GO:1901077) | 6.84795849 |
| 11 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.82769589 |
| 12 | tricarboxylic acid cycle (GO:0006099) | 6.59481529 |
| 13 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.46626941 |
| 14 | cardiac muscle contraction (GO:0060048) | 6.40552200 |
| 15 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.18398531 |
| 16 | regulation of cell communication by electrical coupling (GO:0010649) | 6.16940219 |
| 17 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.98186861 |
| 18 | regulation of actin filament-based movement (GO:1903115) | 5.94512404 |
| 19 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.93227097 |
| 20 | striated muscle contraction (GO:0006941) | 5.90147392 |
| 21 | actomyosin structure organization (GO:0031032) | 5.68081196 |
| 22 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.63453376 |
| 23 | cardiac muscle hypertrophy (GO:0003300) | 5.56129447 |
| 24 | cardiac muscle cell development (GO:0055013) | 5.53429376 |
| 25 | plasma membrane repair (GO:0001778) | 5.52781891 |
| 26 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.52077052 |
| 27 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.50491563 |
| 28 | regulation of sarcomere organization (GO:0060297) | 5.47115695 |
| 29 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.42315421 |
| 30 | skeletal muscle contraction (GO:0003009) | 5.39533290 |
| 31 | striated muscle hypertrophy (GO:0014897) | 5.34284985 |
| 32 | heart process (GO:0003015) | 5.29870523 |
| 33 | heart contraction (GO:0060047) | 5.29870523 |
| 34 | carnitine shuttle (GO:0006853) | 5.29058039 |
| 35 | cardiac cell development (GO:0055006) | 5.17096779 |
| 36 | skeletal muscle fiber development (GO:0048741) | 5.16146989 |
| 37 | actin filament-based movement (GO:0030048) | 5.15563061 |
| 38 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.12154733 |
| 39 | regulation of striated muscle contraction (GO:0006942) | 4.99648017 |
| 40 | myotube cell development (GO:0014904) | 4.98747164 |
| 41 | adult heart development (GO:0007512) | 4.98402902 |
| 42 | regulation of coenzyme metabolic process (GO:0051196) | 4.91915756 |
| 43 | regulation of cofactor metabolic process (GO:0051193) | 4.91915756 |
| 44 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.87009027 |
| 45 | muscle hypertrophy (GO:0014896) | 4.82823806 |
| 46 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.80871162 |
| 47 | muscle tissue morphogenesis (GO:0060415) | 4.64903545 |
| 48 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.56283615 |
| 49 | NADH metabolic process (GO:0006734) | 4.54786673 |
| 50 | skeletal muscle adaptation (GO:0043501) | 4.52157428 |
| 51 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.51785234 |
| 52 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.50389801 |
| 53 | fatty acid transmembrane transport (GO:1902001) | 4.49100218 |
| 54 | muscle fiber development (GO:0048747) | 4.39389136 |
| 55 | regulation of membrane repolarization (GO:0060306) | 4.37563018 |
| 56 | oxidative phosphorylation (GO:0006119) | 4.30257623 |
| 57 | response to inactivity (GO:0014854) | 4.18226127 |
| 58 | glucan biosynthetic process (GO:0009250) | 4.14305617 |
| 59 | glycogen biosynthetic process (GO:0005978) | 4.14305617 |
| 60 | muscle contraction (GO:0006936) | 4.09770058 |
| 61 | respiratory electron transport chain (GO:0022904) | 4.07787897 |
| 62 | regulation of sulfur metabolic process (GO:0042762) | 4.00876252 |
| 63 | striated muscle adaptation (GO:0014888) | 4.00689481 |
| 64 | cardiac muscle cell action potential (GO:0086001) | 3.96183350 |
| 65 | electron transport chain (GO:0022900) | 3.96087000 |
| 66 | skeletal muscle tissue development (GO:0007519) | 3.95716656 |
| 67 | cardiac muscle adaptation (GO:0014887) | 3.95485036 |
| 68 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.95485036 |
| 69 | muscle hypertrophy in response to stress (GO:0003299) | 3.95485036 |
| 70 | heart trabecula formation (GO:0060347) | 3.94665902 |
| 71 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.92533646 |
| 72 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.91933688 |
| 73 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.91616349 |
| 74 | creatine metabolic process (GO:0006600) | 3.89975794 |
| 75 | regulation of cardiac muscle contraction (GO:0055117) | 3.89176258 |
| 76 | cellular polysaccharide catabolic process (GO:0044247) | 3.86479638 |
| 77 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.85188442 |
| 78 | muscle system process (GO:0003012) | 3.84610102 |
| 79 | carnitine transmembrane transport (GO:1902603) | 3.81539931 |
| 80 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.80397845 |
| 81 | glycogen catabolic process (GO:0005980) | 3.77589260 |
| 82 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.76002917 |
| 83 | regulation of the force of heart contraction (GO:0002026) | 3.71664808 |
| 84 | quinone biosynthetic process (GO:1901663) | 3.68513970 |
| 85 | ubiquinone biosynthetic process (GO:0006744) | 3.68513970 |
| 86 | regulation of heart rate (GO:0002027) | 3.66015135 |
| 87 | skeletal muscle tissue regeneration (GO:0043403) | 3.65316907 |
| 88 | striated muscle cell development (GO:0055002) | 3.63252413 |
| 89 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.62853095 |
| 90 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.61604246 |
| 91 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.61604246 |
| 92 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.60867997 |
| 93 | ATP synthesis coupled proton transport (GO:0015986) | 3.60867997 |
| 94 | succinate metabolic process (GO:0006105) | 3.58456203 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 3.57203668 |
| 96 | regulation of sequestering of triglyceride (GO:0010889) | 3.56597562 |
| 97 | positive regulation of cation channel activity (GO:2001259) | 3.56391085 |
| 98 | response to muscle activity (GO:0014850) | 3.53989402 |
| 99 | oxaloacetate metabolic process (GO:0006107) | 3.53264436 |
| 100 | striated muscle atrophy (GO:0014891) | 3.52738261 |
| 101 | 2-oxoglutarate metabolic process (GO:0006103) | 3.52079212 |
| 102 | positive regulation of heart rate (GO:0010460) | 3.50995626 |
| 103 | glucan catabolic process (GO:0009251) | 3.49693810 |
| 104 | neuronal action potential propagation (GO:0019227) | 3.49036532 |
| 105 | ubiquinone metabolic process (GO:0006743) | 3.48770406 |
| 106 | cytidine metabolic process (GO:0046087) | 3.48437258 |
| 107 | cytidine catabolic process (GO:0006216) | 3.48437258 |
| 108 | cytidine deamination (GO:0009972) | 3.48437258 |
| 109 | polysaccharide catabolic process (GO:0000272) | 3.46595787 |
| 110 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.46386144 |
| 111 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.46386144 |
| 112 | negative regulation of protein localization to cell surface (GO:2000009) | 3.46090726 |
| 113 | cardiac conduction (GO:0061337) | 3.43647127 |
| 114 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.43298347 |
| 115 | muscle adaptation (GO:0043500) | 3.42793519 |
| 116 | behavioral response to nicotine (GO:0035095) | 3.36444393 |
| 117 | neuromuscular synaptic transmission (GO:0007274) | 3.33942447 |
| 118 | muscle cell cellular homeostasis (GO:0046716) | 3.32005978 |
| 119 | response to caffeine (GO:0031000) | 3.29447092 |
| 120 | muscle structure development (GO:0061061) | 3.26145494 |
| 121 | muscle organ development (GO:0007517) | 3.23317321 |
| 122 | response to activity (GO:0014823) | 3.20058731 |
| 123 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.19906354 |
| 124 | glycogen metabolic process (GO:0005977) | 3.14278399 |
| 125 | relaxation of muscle (GO:0090075) | 3.07989089 |
| 126 | glucan metabolic process (GO:0044042) | 3.06519861 |
| 127 | cellular glucan metabolic process (GO:0006073) | 3.06519861 |
| 128 | otic vesicle formation (GO:0030916) | 3.02985615 |
| 129 | aspartate family amino acid catabolic process (GO:0009068) | 3.02697503 |
| 130 | muscle cell fate commitment (GO:0042693) | 2.96376446 |
| 131 | muscle organ morphogenesis (GO:0048644) | 2.95912674 |
| 132 | regulation of muscle system process (GO:0090257) | 2.91945538 |
| 133 | regulation of ATPase activity (GO:0043462) | 2.87600404 |
| 134 | regulation of ATP catabolic process (GO:1903289) | 2.87600404 |
| 135 | membrane depolarization during action potential (GO:0086010) | 2.87522558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.99194806 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.73594138 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.39131141 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.31643246 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.36494519 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.36494519 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.32949755 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.18075302 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.06150762 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.03002358 |
| 11 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.85793525 |
| 12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.73301395 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.59039542 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.52548170 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.46134931 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.45065716 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.41495432 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.31537521 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.30582108 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.30158218 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.93463657 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.80197147 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.77006236 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73620250 |
| 25 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.71744795 |
| 26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.70430970 |
| 27 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.57727816 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.52169353 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50273319 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50070673 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49119169 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.47444084 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40223785 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39148455 |
| 35 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.38146363 |
| 36 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.38146363 |
| 37 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.34021595 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33778506 |
| 39 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32783279 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30636325 |
| 41 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.26318304 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.24693257 |
| 43 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.23403965 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21623900 |
| 45 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.21151991 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19602148 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19588200 |
| 48 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.19021478 |
| 49 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16963560 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16955111 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.16610054 |
| 52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15291475 |
| 53 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13979268 |
| 54 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.13949756 |
| 55 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13337537 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12805966 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12527658 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12315879 |
| 59 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12206081 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12034121 |
| 61 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.10366665 |
| 62 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.09819972 |
| 63 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09417256 |
| 64 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09399145 |
| 65 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.08321384 |
| 66 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.07921665 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07692918 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05316574 |
| 69 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05187456 |
| 70 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05056028 |
| 71 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03607087 |
| 72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03396944 |
| 73 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.00760433 |
| 74 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.99916321 |
| 75 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99510554 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99478604 |
| 77 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99459685 |
| 78 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99287309 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99043379 |
| 80 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.98003320 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97948142 |
| 82 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.97897168 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97197787 |
| 84 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.97143975 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96799051 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96186489 |
| 87 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95725753 |
| 88 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.95714651 |
| 89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95527478 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94249999 |
| 91 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94026207 |
| 92 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94022714 |
| 93 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92842976 |
| 94 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.92795191 |
| 95 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92543927 |
| 96 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92496902 |
| 97 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.92413039 |
| 98 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92292145 |
| 99 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92022810 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91736887 |
| 101 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.91460244 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.91094885 |
| 103 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.90313667 |
| 104 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.89603639 |
| 105 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.89074500 |
| 106 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88261443 |
| 107 | TBL1_22424771_ChIP-Seq_293T_Human | 0.88068171 |
| 108 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87976080 |
| 109 | TCF4_23295773_ChIP-Seq_U87_Human | 0.86562568 |
| 110 | VDR_22108803_ChIP-Seq_LS180_Human | 0.86276586 |
| 111 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86009525 |
| 112 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85758653 |
| 113 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.84963149 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84200078 |
| 115 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.83416127 |
| 116 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.82895855 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82633407 |
| 118 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82633407 |
| 119 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.81884891 |
| 120 | FUS_26573619_Chip-Seq_HEK293_Human | 0.81860898 |
| 121 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.81740827 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81672746 |
| 123 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.81369681 |
| 124 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.80503634 |
| 125 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.80281164 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79821920 |
| 127 | NFYA_21822215_ChIP-Seq_K562_Human | 0.79524619 |
| 128 | CBP_21632823_ChIP-Seq_H3396_Human | 0.79227627 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.78293973 |
| 130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.78153418 |
| 131 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.78010071 |
| 132 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.77578395 |
| 133 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77578395 |
| 134 | NFYB_21822215_ChIP-Seq_K562_Human | 0.77305416 |
| 135 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.77100187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.44024095 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 6.31749696 |
| 3 | MP0000751_myopathy | 5.24918651 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.96771737 |
| 5 | MP0000749_muscle_degeneration | 4.91474586 |
| 6 | MP0004215_abnormal_myocardial_fiber | 4.51103899 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.45162806 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.91566138 |
| 9 | MP0005330_cardiomyopathy | 3.55749550 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.13109455 |
| 11 | MP0005620_abnormal_muscle_contractility | 3.08561234 |
| 12 | MP0002106_abnormal_muscle_physiology | 3.08294140 |
| 13 | MP0004130_abnormal_muscle_cell | 3.07901612 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.95652005 |
| 15 | MP0000750_abnormal_muscle_regeneration | 2.81732249 |
| 16 | MP0002269_muscular_atrophy | 2.61852575 |
| 17 | MP0003137_abnormal_impulse_conducting | 2.60274356 |
| 18 | MP0008775_abnormal_heart_ventricle | 2.58775905 |
| 19 | MP0004484_altered_response_of | 2.56563352 |
| 20 | MP0005369_muscle_phenotype | 2.55233665 |
| 21 | MP0000759_abnormal_skeletal_muscle | 2.42419306 |
| 22 | MP0000747_muscle_weakness | 2.38263584 |
| 23 | MP0001544_abnormal_cardiovascular_syste | 2.28353435 |
| 24 | MP0005385_cardiovascular_system_phenoty | 2.28353435 |
| 25 | MP0010630_abnormal_cardiac_muscle | 2.23787282 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 2.11283733 |
| 27 | MP0006138_congestive_heart_failure | 2.00679458 |
| 28 | MP0004233_abnormal_muscle_weight | 1.96807118 |
| 29 | MP0004085_abnormal_heartbeat | 1.92267482 |
| 30 | MP0003828_pulmonary_edema | 1.82144268 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.79977233 |
| 32 | MP0002127_abnormal_cardiovascular_syste | 1.78519812 |
| 33 | MP0004270_analgesia | 1.75508796 |
| 34 | MP0004510_myositis | 1.70358057 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.69840922 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.36206611 |
| 37 | MP0005670_abnormal_white_adipose | 1.33096474 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.22204570 |
| 39 | MP0006035_abnormal_mitochondrial_morpho | 1.19391498 |
| 40 | MP0002108_abnormal_muscle_morphology | 1.19041909 |
| 41 | MP0004147_increased_porphyrin_level | 1.13196071 |
| 42 | MP0001661_extended_life_span | 1.00882060 |
| 43 | MP0000343_altered_response_to | 1.00822860 |
| 44 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98639151 |
| 45 | MP0000266_abnormal_heart_morphology | 0.97521968 |
| 46 | MP0003045_fibrosis | 0.93892233 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 0.92858761 |
| 48 | MP0005266_abnormal_metabolism | 0.90841990 |
| 49 | MP0006276_abnormal_autonomic_nervous | 0.89727746 |
| 50 | MP0005165_increased_susceptibility_to | 0.85442804 |
| 51 | MP0004043_abnormal_pH_regulation | 0.85291296 |
| 52 | MP0001984_abnormal_olfaction | 0.84043628 |
| 53 | MP0000230_abnormal_systemic_arterial | 0.82345894 |
| 54 | MP0002234_abnormal_pharynx_morphology | 0.81520317 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 0.80489019 |
| 56 | MP0005375_adipose_tissue_phenotype | 0.75153908 |
| 57 | MP0008872_abnormal_physiological_respon | 0.74855003 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 0.74533113 |
| 59 | MP0002876_abnormal_thyroid_physiology | 0.73495682 |
| 60 | MP0002734_abnormal_mechanical_nocicepti | 0.69431678 |
| 61 | MP0003279_aneurysm | 0.69403594 |
| 62 | MP0010368_abnormal_lymphatic_system | 0.69277877 |
| 63 | MP0005645_abnormal_hypothalamus_physiol | 0.68992467 |
| 64 | MP0009745_abnormal_behavioral_response | 0.66970350 |
| 65 | MP0003136_yellow_coat_color | 0.66392248 |
| 66 | MP0002822_catalepsy | 0.64895359 |
| 67 | MP0002272_abnormal_nervous_system | 0.64167059 |
| 68 | MP0002971_abnormal_brown_adipose | 0.63666243 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 0.63549362 |
| 70 | MP0005423_abnormal_somatic_nervous | 0.63484551 |
| 71 | MP0000733_abnormal_muscle_development | 0.63319271 |
| 72 | MP0008877_abnormal_DNA_methylation | 0.60806790 |
| 73 | MP0001485_abnormal_pinna_reflex | 0.60199335 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 0.60082737 |
| 75 | MP0003879_abnormal_hair_cell | 0.58888417 |
| 76 | MP0002128_abnormal_blood_circulation | 0.57760199 |
| 77 | MP0009046_muscle_twitch | 0.56539146 |
| 78 | MP0001486_abnormal_startle_reflex | 0.55522967 |
| 79 | MP0002067_abnormal_sensory_capabilities | 0.54110389 |
| 80 | MP0005332_abnormal_amino_acid | 0.52187477 |
| 81 | MP0000013_abnormal_adipose_tissue | 0.51971826 |
| 82 | MP0005253_abnormal_eye_physiology | 0.50032296 |
| 83 | MP0001501_abnormal_sleep_pattern | 0.49772160 |
| 84 | MP0004885_abnormal_endolymph | 0.49130737 |
| 85 | MP0009780_abnormal_chondrocyte_physiolo | 0.48661806 |
| 86 | MP0003195_calcinosis | 0.47570909 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.45395912 |
| 88 | MP0002064_seizures | 0.44934475 |
| 89 | MP0005451_abnormal_body_composition | 0.44284319 |
| 90 | MP0000372_irregular_coat_pigmentation | 0.43999915 |
| 91 | MP0005334_abnormal_fat_pad | 0.43422907 |
| 92 | MP0009697_abnormal_copulation | 0.43309049 |
| 93 | MP0005083_abnormal_biliary_tract | 0.42641774 |
| 94 | MP0004134_abnormal_chest_morphology | 0.42548778 |
| 95 | MP0003011_delayed_dark_adaptation | 0.41382709 |
| 96 | MP0001440_abnormal_grooming_behavior | 0.41184113 |
| 97 | MP0001529_abnormal_vocalization | 0.40616061 |
| 98 | MP0002066_abnormal_motor_capabilities/c | 0.40022134 |
| 99 | MP0000767_abnormal_smooth_muscle | 0.39951597 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.39912881 |
| 101 | MP0002733_abnormal_thermal_nociception | 0.38704012 |
| 102 | MP0005646_abnormal_pituitary_gland | 0.38523578 |
| 103 | MP0005319_abnormal_enzyme/_coenzyme | 0.37660227 |
| 104 | MP0001968_abnormal_touch/_nociception | 0.37640172 |
| 105 | MP0000003_abnormal_adipose_tissue | 0.36201621 |
| 106 | MP0002638_abnormal_pupillary_reflex | 0.35862290 |
| 107 | MP0005535_abnormal_body_temperature | 0.35728291 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.35579366 |
| 109 | MP0004924_abnormal_behavior | 0.34320687 |
| 110 | MP0005386_behavior/neurological_phenoty | 0.34320687 |
| 111 | MP0005171_absent_coat_pigmentation | 0.31987045 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.30618440 |
| 113 | MP0008569_lethality_at_weaning | 0.29640484 |
| 114 | MP0003948_abnormal_gas_homeostasis | 0.29166172 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.26916828 |
| 116 | MP0005452_abnormal_adipose_tissue | 0.26016910 |
| 117 | MP0009115_abnormal_fat_cell | 0.25826782 |
| 118 | MP0005595_abnormal_vascular_smooth | 0.25787824 |
| 119 | MP0004142_abnormal_muscle_tone | 0.23386490 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.23156402 |
| 121 | MP0002909_abnormal_adrenal_gland | 0.22901527 |
| 122 | MP0001853_heart_inflammation | 0.22774179 |
| 123 | MP0002925_abnormal_cardiovascular_devel | 0.21422298 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.19938170 |
| 125 | MP0008961_abnormal_basal_metabolism | 0.19088376 |
| 126 | MP0005085_abnormal_gallbladder_physiolo | 0.17997931 |
| 127 | MP0005623_abnormal_meninges_morphology | 0.17407465 |
| 128 | MP0003984_embryonic_growth_retardation | 0.16229244 |
| 129 | MP0002118_abnormal_lipid_homeostasis | 0.14634166 |
| 130 | MP0000678_abnormal_parathyroid_gland | 0.14309465 |
| 131 | MP0002088_abnormal_embryonic_growth/wei | 0.14249731 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.13781337 |
| 133 | MP0003953_abnormal_hormone_level | 0.13746542 |
| 134 | MP0005187_abnormal_penis_morphology | 0.12930902 |
| 135 | MP0001614_abnormal_blood_vessel | 0.12747009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.25528190 |
| 2 | Calf muscle hypertrophy (HP:0008981) | 6.98165481 |
| 3 | Sudden death (HP:0001699) | 6.97130136 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 6.97076415 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.84654341 |
| 6 | Ventricular tachycardia (HP:0004756) | 5.80802146 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.46959335 |
| 8 | Myoglobinuria (HP:0002913) | 5.27287925 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 5.24621112 |
| 10 | Atrial fibrillation (HP:0005110) | 5.16252382 |
| 11 | Subaortic stenosis (HP:0001682) | 5.09615462 |
| 12 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.09615462 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 4.81363152 |
| 14 | Primary atrial arrhythmia (HP:0001692) | 4.78708105 |
| 15 | Muscle fiber inclusion bodies (HP:0100299) | 4.67594191 |
| 16 | Supraventricular tachycardia (HP:0004755) | 4.61870785 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.61146222 |
| 18 | Lipoatrophy (HP:0100578) | 4.57536011 |
| 19 | EMG: myopathic abnormalities (HP:0003458) | 4.52958931 |
| 20 | Supraventricular arrhythmia (HP:0005115) | 4.49389978 |
| 21 | Rhabdomyolysis (HP:0003201) | 4.25285290 |
| 22 | Nemaline bodies (HP:0003798) | 3.99352696 |
| 23 | Syncope (HP:0001279) | 3.96997835 |
| 24 | Increased connective tissue (HP:0009025) | 3.96361981 |
| 25 | Right ventricular cardiomyopathy (HP:0011663) | 3.96266561 |
| 26 | Dilated cardiomyopathy (HP:0001644) | 3.91134701 |
| 27 | Palpitations (HP:0001962) | 3.82898258 |
| 28 | Myotonia (HP:0002486) | 3.80027369 |
| 29 | Difficulty running (HP:0009046) | 3.79550648 |
| 30 | Bundle branch block (HP:0011710) | 3.75648682 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 3.68784011 |
| 32 | Absent phalangeal crease (HP:0006109) | 3.62862527 |
| 33 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.60625009 |
| 34 | Type 1 muscle fiber predominance (HP:0003803) | 3.55563672 |
| 35 | Prolonged QT interval (HP:0001657) | 3.55491093 |
| 36 | Calcaneovalgus deformity (HP:0001848) | 3.47866084 |
| 37 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.40674157 |
| 38 | Acute necrotizing encephalopathy (HP:0006965) | 3.39936098 |
| 39 | Ventricular arrhythmia (HP:0004308) | 3.33637789 |
| 40 | Heart block (HP:0012722) | 3.30128339 |
| 41 | Frequent falls (HP:0002359) | 3.25036907 |
| 42 | Hepatic necrosis (HP:0002605) | 3.24832848 |
| 43 | Muscle stiffness (HP:0003552) | 3.21711054 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 3.15397309 |
| 45 | Deformed tarsal bones (HP:0008119) | 3.12548830 |
| 46 | Abnormal atrioventricular conduction (HP:0005150) | 3.10169260 |
| 47 | Abnormal finger flexion creases (HP:0006143) | 3.04095681 |
| 48 | Hepatocellular necrosis (HP:0001404) | 3.03283292 |
| 49 | Areflexia of lower limbs (HP:0002522) | 3.02458649 |
| 50 | Distal arthrogryposis (HP:0005684) | 2.99616280 |
| 51 | Atrioventricular block (HP:0001678) | 2.94430184 |
| 52 | Left ventricular hypertrophy (HP:0001712) | 2.88896313 |
| 53 | Progressive macrocephaly (HP:0004481) | 2.85640603 |
| 54 | Malignant hyperthermia (HP:0002047) | 2.84199888 |
| 55 | Acute encephalopathy (HP:0006846) | 2.84159853 |
| 56 | Neck muscle weakness (HP:0000467) | 2.84107906 |
| 57 | Mitochondrial inheritance (HP:0001427) | 2.81869044 |
| 58 | Difficulty climbing stairs (HP:0003551) | 2.77649622 |
| 59 | Increased CSF lactate (HP:0002490) | 2.71161471 |
| 60 | Rimmed vacuoles (HP:0003805) | 2.67914470 |
| 61 | Abnormal EKG (HP:0003115) | 2.67835887 |
| 62 | Round ear (HP:0100830) | 2.65574559 |
| 63 | Ventricular fibrillation (HP:0001663) | 2.61387408 |
| 64 | Myopathic facies (HP:0002058) | 2.57837883 |
| 65 | Exercise intolerance (HP:0003546) | 2.57579294 |
| 66 | Fetal akinesia sequence (HP:0001989) | 2.54307468 |
| 67 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.54186613 |
| 68 | Abnormality of alanine metabolism (HP:0010916) | 2.54186613 |
| 69 | Hyperalaninemia (HP:0003348) | 2.54186613 |
| 70 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.50710079 |
| 71 | Cerebral edema (HP:0002181) | 2.46793658 |
| 72 | Weak cry (HP:0001612) | 2.44574774 |
| 73 | Increased variability in muscle fiber diameter (HP:0003557) | 2.43736298 |
| 74 | Lactic acidosis (HP:0003128) | 2.36962196 |
| 75 | Muscular dystrophy (HP:0003560) | 2.29955773 |
| 76 | Ketoacidosis (HP:0001993) | 2.26979638 |
| 77 | Palmoplantar keratoderma (HP:0000982) | 2.25122469 |
| 78 | Bulbar palsy (HP:0001283) | 2.16495709 |
| 79 | Ulnar deviation of the wrist (HP:0003049) | 2.16476799 |
| 80 | Respiratory failure (HP:0002878) | 2.15651233 |
| 81 | Increased muscle lipid content (HP:0009058) | 2.15542086 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15039285 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.15039285 |
| 84 | Limb-girdle muscle atrophy (HP:0003797) | 2.12606490 |
| 85 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11761337 |
| 86 | Generalized muscle weakness (HP:0003324) | 2.09909481 |
| 87 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.09049894 |
| 88 | Hypoglycemic coma (HP:0001325) | 2.05082734 |
| 89 | Type 2 muscle fiber atrophy (HP:0003554) | 2.02836252 |
| 90 | Hip contracture (HP:0003273) | 2.01638301 |
| 91 | EMG: neuropathic changes (HP:0003445) | 2.01067679 |
| 92 | Progressive muscle weakness (HP:0003323) | 1.99192201 |
| 93 | Slender build (HP:0001533) | 1.97657182 |
| 94 | Pheochromocytoma (HP:0002666) | 1.96851958 |
| 95 | Increased intramyocellular lipid droplets (HP:0012240) | 1.96258554 |
| 96 | Ragged-red muscle fibers (HP:0003200) | 1.93788166 |
| 97 | Toxemia of pregnancy (HP:0100603) | 1.93178258 |
| 98 | Gowers sign (HP:0003391) | 1.92431934 |
| 99 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.92359529 |
| 100 | Conjunctival hamartoma (HP:0100780) | 1.91492312 |
| 101 | Scapular winging (HP:0003691) | 1.90747058 |
| 102 | Facial diplegia (HP:0001349) | 1.90385528 |
| 103 | Hypoplastic ischia (HP:0003175) | 1.89035380 |
| 104 | Distal lower limb amyotrophy (HP:0008944) | 1.88971772 |
| 105 | Testicular atrophy (HP:0000029) | 1.87617426 |
| 106 | Proximal amyotrophy (HP:0007126) | 1.85564460 |
| 107 | Abnormality of glycolysis (HP:0004366) | 1.85543238 |
| 108 | Increased serum pyruvate (HP:0003542) | 1.85543238 |
| 109 | Neoplasm of the adrenal gland (HP:0100631) | 1.84018628 |
| 110 | Waddling gait (HP:0002515) | 1.83600700 |
| 111 | Esophageal neoplasm (HP:0100751) | 1.83427455 |
| 112 | Neoplasm of head and neck (HP:0012288) | 1.83427455 |
| 113 | Increased serum lactate (HP:0002151) | 1.80931371 |
| 114 | Fatigable weakness (HP:0003473) | 1.78049156 |
| 115 | Abnormality of the neuromuscular junction (HP:0003398) | 1.78049156 |
| 116 | Neuroendocrine neoplasm (HP:0100634) | 1.77549487 |
| 117 | Hyperkalemia (HP:0002153) | 1.77504254 |
| 118 | Nonprogressive disorder (HP:0003680) | 1.77052584 |
| 119 | Congestive heart failure (HP:0001635) | 1.75942949 |
| 120 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.75831232 |
| 121 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.74206915 |
| 122 | Muscle fiber atrophy (HP:0100295) | 1.69950707 |
| 123 | Abnormality of the foot musculature (HP:0001436) | 1.67750570 |
| 124 | Paralysis (HP:0003470) | 1.64899223 |
| 125 | Abnormality of the calcaneus (HP:0008364) | 1.63515314 |
| 126 | Long clavicles (HP:0000890) | 1.54528492 |
| 127 | Large for gestational age (HP:0001520) | 1.53400634 |
| 128 | Hyperglycinuria (HP:0003108) | 1.51150592 |
| 129 | Oligomenorrhea (HP:0000876) | 1.47482852 |
| 130 | Abnormality of potassium homeostasis (HP:0011042) | 1.47250320 |
| 131 | Steppage gait (HP:0003376) | 1.45951827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.16952184 |
| 2 | TTN | 5.41489873 |
| 3 | PHKG2 | 4.58068383 |
| 4 | PHKG1 | 4.58068383 |
| 5 | PDK3 | 3.37069798 |
| 6 | PDK4 | 3.37069798 |
| 7 | MYLK | 3.16578142 |
| 8 | LMTK2 | 2.78892694 |
| 9 | ZAK | 2.57942697 |
| 10 | MUSK | 2.54393759 |
| 11 | BCKDK | 2.52140878 |
| 12 | PINK1 | 2.46547582 |
| 13 | PIK3CA | 2.45909698 |
| 14 | NEK1 | 2.43517319 |
| 15 | DMPK | 2.30150640 |
| 16 | PDK2 | 2.06912325 |
| 17 | STK24 | 2.00160796 |
| 18 | NME1 | 1.82523065 |
| 19 | CASK | 1.79780204 |
| 20 | FRK | 1.73631612 |
| 21 | TIE1 | 1.67957918 |
| 22 | GRK7 | 1.67747349 |
| 23 | MARK1 | 1.50489066 |
| 24 | INSRR | 1.43065189 |
| 25 | PIK3CG | 1.42444436 |
| 26 | STK38L | 1.34927895 |
| 27 | PKN2 | 1.32336620 |
| 28 | MAP2K3 | 1.28175992 |
| 29 | MAP3K7 | 1.25967518 |
| 30 | MAPK12 | 1.23655439 |
| 31 | TRPM7 | 1.11963027 |
| 32 | CAMK2D | 1.05477914 |
| 33 | PRKAA1 | 1.02879119 |
| 34 | PRKAA2 | 0.94356658 |
| 35 | SGK2 | 0.85733856 |
| 36 | FLT3 | 0.84647377 |
| 37 | BMPR1B | 0.82789615 |
| 38 | PKN1 | 0.81824170 |
| 39 | ADRBK2 | 0.81389391 |
| 40 | WNK3 | 0.80114863 |
| 41 | ILK | 0.80101879 |
| 42 | DAPK2 | 0.78321685 |
| 43 | MAP2K4 | 0.76815766 |
| 44 | PRKD1 | 0.75824914 |
| 45 | MAP2K7 | 0.73423084 |
| 46 | LIMK1 | 0.72981403 |
| 47 | STK4 | 0.72713716 |
| 48 | OXSR1 | 0.70279584 |
| 49 | PNCK | 0.69440316 |
| 50 | ROCK1 | 0.69385499 |
| 51 | GRK1 | 0.68587183 |
| 52 | CAMK4 | 0.68294501 |
| 53 | TAOK2 | 0.64527798 |
| 54 | CDC42BPA | 0.64493280 |
| 55 | SGK3 | 0.64207628 |
| 56 | TRIB3 | 0.62375714 |
| 57 | NLK | 0.61867674 |
| 58 | TNIK | 0.61402225 |
| 59 | MAP4K2 | 0.59487360 |
| 60 | CAMK2A | 0.57888981 |
| 61 | PAK3 | 0.57713140 |
| 62 | MAP3K5 | 0.56777289 |
| 63 | NEK9 | 0.55308481 |
| 64 | CCNB1 | 0.54000151 |
| 65 | STK39 | 0.53414867 |
| 66 | MAP2K6 | 0.52923133 |
| 67 | PRKCE | 0.52479523 |
| 68 | CAMK1 | 0.52448882 |
| 69 | PRKACB | 0.51154189 |
| 70 | CAMK2G | 0.50038082 |
| 71 | ACVR1B | 0.49272278 |
| 72 | AKT3 | 0.48880686 |
| 73 | RPS6KC1 | 0.48295789 |
| 74 | RPS6KL1 | 0.48295789 |
| 75 | PRKACA | 0.48106769 |
| 76 | MAP2K1 | 0.48068473 |
| 77 | MAPK7 | 0.46126595 |
| 78 | MAP3K3 | 0.45649637 |
| 79 | DAPK3 | 0.43527252 |
| 80 | NUAK1 | 0.42665197 |
| 81 | SGK1 | 0.38980505 |
| 82 | CAMK2B | 0.38940425 |
| 83 | RPS6KA6 | 0.38589558 |
| 84 | WNK1 | 0.38233530 |
| 85 | TLK1 | 0.37458096 |
| 86 | MAP3K4 | 0.36301384 |
| 87 | STK38 | 0.35910560 |
| 88 | PRKG1 | 0.35846268 |
| 89 | AKT2 | 0.35685577 |
| 90 | DYRK1B | 0.35240308 |
| 91 | IRAK3 | 0.34949122 |
| 92 | SGK494 | 0.34659697 |
| 93 | SGK223 | 0.34659697 |
| 94 | PRPF4B | 0.34620899 |
| 95 | MAPKAPK3 | 0.33433973 |
| 96 | CAMKK2 | 0.32976564 |
| 97 | MAPK4 | 0.32820845 |
| 98 | PRKACG | 0.32348743 |
| 99 | TAOK3 | 0.31659472 |
| 100 | PTK2B | 0.30969024 |
| 101 | EPHA3 | 0.30107410 |
| 102 | STK11 | 0.29994930 |
| 103 | TGFBR2 | 0.29865853 |
| 104 | WNK4 | 0.28939131 |
| 105 | STK16 | 0.28882299 |
| 106 | MAPK11 | 0.28396033 |
| 107 | ERBB3 | 0.27952154 |
| 108 | RPS6KB1 | 0.21836413 |
| 109 | KDR | 0.21519808 |
| 110 | TNK2 | 0.19705895 |
| 111 | EIF2AK2 | 0.19033052 |
| 112 | PRKCQ | 0.18396734 |
| 113 | MOS | 0.17206049 |
| 114 | RIPK1 | 0.16253739 |
| 115 | ROCK2 | 0.16162048 |
| 116 | MKNK2 | 0.16123874 |
| 117 | MAP3K12 | 0.15865291 |
| 118 | DYRK2 | 0.15234284 |
| 119 | RPS6KA3 | 0.15203677 |
| 120 | NME2 | 0.13301488 |
| 121 | LATS1 | 0.13295905 |
| 122 | ADRBK1 | 0.12973164 |
| 123 | RPS6KA2 | 0.12948683 |
| 124 | PRKCH | 0.12577128 |
| 125 | TTK | 0.12244427 |
| 126 | PRKG2 | 0.12145526 |
| 127 | MAPK15 | 0.12138540 |
| 128 | TSSK6 | 0.11836454 |
| 129 | PRKCG | 0.11809854 |
| 130 | CSNK1G1 | 0.11776546 |
| 131 | MAPK13 | 0.09859924 |
| 132 | RPS6KA1 | 0.09026728 |
| 133 | PDK1 | 0.08334688 |
| 134 | PRKCA | 0.07634263 |
| 135 | PLK2 | 0.06915595 |
| 136 | CDK8 | 0.06310231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.17343457 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.22806700 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.16624165 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.84589381 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.63343473 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.54079315 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.42172084 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 3.37311104 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.11102615 |
| 10 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.71155319 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.58398917 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.53743660 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.48285557 |
| 14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.27762988 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.17077260 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13834687 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.13797320 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.98635846 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95583126 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.50999980 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.49146488 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.40816093 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.39773526 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.35257006 |
| 25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34935946 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28580102 |
| 27 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.25086985 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22533418 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.16603773 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16505145 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14598342 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12173165 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08758234 |
| 34 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.07960161 |
| 35 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.04644697 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03029605 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99192879 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 0.99091155 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98280826 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93986403 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92505816 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89853923 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84248220 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.79694281 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79524365 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76071507 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74990819 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74505587 |
| 49 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71217390 |
| 50 | Salivary secretion_Homo sapiens_hsa04970 | 0.70038948 |
| 51 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68230335 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66924248 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 0.65670370 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 0.65577437 |
| 55 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63512306 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59096708 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58267067 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.57878724 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56832480 |
| 60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53332855 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 0.52884141 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50689076 |
| 63 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49732487 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48506115 |
| 65 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47730801 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47151380 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46340512 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45073328 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.44404250 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.43863830 |
| 71 | Focal adhesion_Homo sapiens_hsa04510 | 0.43223358 |
| 72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.42638662 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41755179 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41484146 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.40677083 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36775247 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 0.36045993 |
| 78 | Circadian entrainment_Homo sapiens_hsa04713 | 0.35836295 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35591407 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34780381 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.33895975 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33398535 |
| 83 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.32509149 |
| 84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.31571517 |
| 85 | Tight junction_Homo sapiens_hsa04530 | 0.30764305 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.30114290 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29931150 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29573672 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29168892 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28511552 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28135337 |
| 92 | Protein export_Homo sapiens_hsa03060 | 0.27896477 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.25131330 |
| 94 | RNA polymerase_Homo sapiens_hsa03020 | 0.24538976 |
| 95 | Taste transduction_Homo sapiens_hsa04742 | 0.22157757 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.21875216 |
| 97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20394314 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19033557 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17479979 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17438757 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.17021389 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15912697 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.15244889 |
| 104 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.12694603 |
| 105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.11380849 |
| 106 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.11097068 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.10050873 |
| 108 | Morphine addiction_Homo sapiens_hsa05032 | 0.09277910 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09240521 |
| 110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.08613550 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.07026281 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06742455 |
| 113 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.04079046 |
| 114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.03665789 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.03021479 |
| 116 | Adherens junction_Homo sapiens_hsa04520 | 0.02611760 |
| 117 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.02584589 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.01681513 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.01038027 |
| 120 | Amphetamine addiction_Homo sapiens_hsa05031 | -0.1053421 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0802428 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0680625 |
| 123 | RNA degradation_Homo sapiens_hsa03018 | -0.0536283 |
| 124 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0520412 |
| 125 | Proteasome_Homo sapiens_hsa03050 | -0.0391185 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | -0.0245060 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | -0.0235725 |

